by Laura Smith | Jul 21, 2022 | Communications, Weekly Cannabis News
June 24th – July 1st, 2022 CannTeen Study Results: Implications of Cannabis Use During Adolescence Results from the study showed that adolescent users were significantly more likely to have severe cannabis use disorder (CUD) compared to adult users, raising the...by Laura Smith | Jun 24, 2022 | Communications, Weekly Cannabis News
June 17th – June 24th, 2022 Cognitive Behavioral Therapy (CBT) to Stop Cannabis in First-Episode Psychosis (FEP) Patients Specific CBT treatments may be good interventional strategies to reduce cannabis use severity in FEB cannabis consumers, a new study suggests....by Laura Smith | Jun 17, 2022 | Communications, Weekly Cannabis News
June 10th – June 17th, 2022 Effects of Cannabis Exposure on DNA Methylation in Sperm Cells Findings may provide a better understanding on the consequences of paternal cannabis use on DNA. Cannabis is the most widely illicit drug consumed in the US, with increasing use...by Laura Smith | Jun 15, 2022 | Communications, Weekly Cannabis News
May 27th – June 3rd, 2022 Cannabinoid Receptor 1 Blockade: A Novel Therapeutic Target to Treat Lower Urinary Tract Symptoms (LUTSs)? Administration of a CB1R antagonist decreased LUTSs in a mouse model of induced bladder dysfunction, a new study suggests. The...by Laura Smith | Jun 14, 2022 | Communications, Weekly Cannabis News
May 20th – May 27th, 2022 Medical Cannabis Inhalers to Reduce Pain? Following medical cannabis inhalation, pain and opioid use were reduced while overall quality of life (QoL) was improved, a new study suggests. Medical cannabis has long been viewed as an alternative...by Laura Smith | Jun 13, 2022 | Communications, Weekly Cannabis News
May 13th -May 20th 2022 Medical Cannabis to Reduce Cancer-Associated Symptoms: Results from a Prospective Longitudinal Study Patients’ surveys indicated a decrease in total cancer symptoms burden during six months of medical cannabis treatment. Cancer development is...